Article info
PDFCorrespondence
Clinical trial and ‘real-world’ data support switching from a bio-originator to its biosimilar
- Correspondence to Professor Jonathan Kay, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA 01605, USA; jonathan.kay{at}umassmemorial.org
Citation
Clinical trial and ‘real-world’ data support switching from a bio-originator to its biosimilar
Publication history
- Received December 31, 2018
- Accepted January 2, 2019
- First published January 18, 2019.
Online issue publication
March 19, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.